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Incidence of ESRD 
(Klag et al JAMA 1997) 
• Black Americans have a 2-4 fold higher 
incidence of ESRD compared with Whites 
• When GFR is between 60-80 ml/min, the 
Black population presents higher systolic 
BP and diabetes mellitus prevalence, 
albuminuria and hyperuricemia (Peralta et 
al  NDT 2010).  
• Higher death risk than W before ESRD! 
 

HTN  nephrosclerosis in AA 
R Toto KI 2003  
 
• Incidence of HTN is 5 times higher as cause 
of ESRD in AA compared to non AA 
• HTN is more severe, develops earlier and is 
more difficult to control in AA 
• Role of socioeconomic status and access to 
medical care, high salt intake, obesity, low 





 Chromosome 22 

Krzesinski J-M and Cohen E., Acta Clinica Belgica 2007, 62, 5-14. 
genes 
How to manage HTN with CKD: 
Dietary approach 
 
• Low salt diet  
• DASH diet (fruits, vegetables, fresh low fat 
dairy products) 
• Physical activity and low caloric diet 
• Low proteins (if proteinuria) and low lipids 
in the diet 
Role of sodium intake in the renal 
dysfunction progression 
Why is salt-sensitive HTA so common in Blacks? 
(Campese NDT 1996) 
How to manage HTN with CKD: 
Target BP and first line anti HTA drug 
 
• Target BP < 130/80 mmHg (or even lower) 
• RAS blocker must be the first choice! 

Hebert, L. A. et al. Hypertension 1997;30:428-435 
Estimated mean change in GFR in stage 3 CKD 
according to BP target (MDRD study) 
UBP: 140/90 
LBP: 125/75 
Successful BP control in the AASK study 
(Wright et al Arch Int Med 2002) 
• 1094 AA HT, GFR between 20-65 ml/min/1.73m² due to 
HTA 
• DB Randomization to goal mean BP of either 102-107 
mmHg (usual MAP goal) or 92 mmHg or less (low MAP 
goal) with either metoprolol, ramipril or amlodipine (+ if 
needed furosemide, doxazosin, clonidine or hydralazine) 
• 79% achieved a BP < 140/90 mmHg after 14 months 










In CKD Blacks, 
need for lower target 
BP, thus insist on 
low salt diet, RAS 
blocker and add 
other antiHTA   
(Diuretics, BBl, 
CCBl) 
Other interventions to reduce the 
risk of CKD progression 
 
• HyperPTH (Ca, Vit D, low P diet) 
• Anemia (Iron, ESA) 
• Metabolic acidosis (NaHCO3) 




Vit D, a new hope for CKD prevention (with RAS inhibitors)  
Conclusions 
Hypertension is frequent in Chronic Kidney Disease. 
In Blacks, a genetic predisposition to HT 
nephrosclerosis explains the high prevalence of 
ESRD and some resistance to treatment. 
  Blood pressure control (target < 130/80 mmHg) slows 
the rate of decline in renal function, especially when 
proteinuria is present 
A Dash diet with Low salt is recommended!  
 
Multiple antihypertensive drugs are often required to 
achieve BP goal (Renin-angiotensin inhibitors, 
Calcium channel blockers and Diuretics) 
 
 EPIDEMIOLOGY of  CHRONIC KIDNEY DISEASE IN  
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Dr Ernest K. Sumaili 
Thank you for your attention 
Effect of different sodium intakes on BP 
(Sacks et al NEJM 2001) 
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